Printer Friendly
The Free Library
14,503,364 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Prostate Disease Research.


Men experience a high probability of prostate health problems as they grow older, including benign prostatic hypertrophy Benign prostatic hypertrophy (BPH)
Benign prostatic hypertrophy is an enlargement of the prostate that is not cancerous. However, it may cause problems with urinating or other symptoms.
 (BPH BPH
abbr.
benign prostatic hyperplasia


BPH
Benign prostatic hypertrophy, a very common noncancerous cause of prostatic enlargement in older men.
), prostatic intraepithelial neoplasia--a putative precursor for cancer--and prostate cancer. Risk factors for aberrant prostate growth include age, endocrine status, race, genetics, and environmental factors. In the United States, prostate cancer has become the most frequently diagnosed neoplasm neoplasm or tumor, tissue composed of cells that grow in an abnormal way. Normal tissue is growth-limited, i.e., cell reproduction is equal to cell death.  and the second leading cause of cancer mortality in men.

Little is known about the regulation of the age-related growth process of the prostate and its relationship to BPH and cancer. There is growing concern that environmental factors including in utero and childhood exposures to hormonally active agents may be modifying factors. Independent of aging, both hereditary and environmental factors have been found to influence the rate of prostate growth. The significance of these findings is that the risk associated with such factors is potentially modifiable.

In an effort to increase research on prostate disease, including the role of environmental factors, the NIEHS NIEHS National Institute of Environmental Health Sciences (NIH, DHHS)  is participating in the following multi-institute program announcements:

* Molecular Epidemiology of Prostate Carcinogenesis (PA-99-055) Stimulates the development of biomarkers of prostate cancer risk and tumor aggressiveness for use in chemoprevention che·mo·pre·ven·tion
n.
The use of chemical agents, drugs, or food supplements to prevent disease.


chemoprevention 
 studies

* Biology, Development, and Progression of Malignant Prostate Disease (PA-99-081) Encourages new projects focusing on the biology that underlies the development and progression of malignant prostate disease

The National Institute of Diabetes and Digestive and Kidney Diseases About NIDDK
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), of the U.S. National Institutes of Health, conducts and supports research on many of the most serious diseases affecting public health.
 and the NIEHS recently cosponsored a request for applications titled "Cell-Specific Delineation of Prostate and Genitourinary genitourinary /gen·i·to·uri·nary/ (jen?i-to-u´ri-nar-e) pertaining to the genital and urinary organs.

gen·i·to·u·ri·nar·y
adj. Abbr.
 Development" to encourage the development of new research tools and methods to study the development and biology of the prostate and genitourinary tract. As a result of its initiative activities, the NIEHS currently supports five new research projects investigating the regulation of prostate growth.

To review the current status of the epidemiological and clinical data as well as explore the state of the knowledge on the biologic mechanisms involved in regulating the growth process, the NIEHS cosponsored a workshop on prostate growth and aging on 13-15 September 2000 with the National Institute of Diabetes and Digestive and Kidney Diseases, the National Institute on Aging The National Institute on Aging is a division of the U.S. National Institutes of Health, located in Bethesda, Maryland.

Formed in 1974, NIA's mission is to improve the health and well-being of older Americans through research. It is the primary U.S.
, and the National Cancer Institute. The results of this workshop will provide guidance on the design of future initiatives for advancing research on BPH and prostate cancer. The NIEHS will continue to support research to further advance our knowledge of the role of environmental agents and/or factors in hyperplasia, neoplasia, and cancer of the prostate.

For additional information, please contact Mike McClure, e-mail: mcclure@niehs.nih.gov.
COPYRIGHT 2001 National Institute of Environmental Health Sciences
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2001, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Environmental Health Perspectives
Date:Jul 1, 2001
Words:413
Previous Article:Reduction of Sperm Motility in a Male Laboratory Worker Exposed to Solvents: A Case Study.
Next Article:Health Effects of Chemical Contaminants in Drinking Water.



Related Articles
Teams implicate new gene in prostate cancer.(Brief Article)
The Public Health Improvement Act of 2000.(Brief Article)
Role of Hormones and Growth Factors in Prostate Cancer.
Role of Hormones and Growth Factors in Prostate Cancer.
Role of Hormones and Growth Factors in Prostate Cancer.
CHECKUP TEA AND CHOCOLATE: NOT A BIT OF SYMPATHY NEEDED.(U)
LEARNING A LESSON IN HOW TO SURVIVE PROSTATE CANCER.(L.A. LIFE)(Statistical Data Included)
A tomato a day. (Lifelines).(Brief Article)
Protein flags colon, prostate cancers. (Cancer).(huntingtin interacting protein 1)(Brief Article)
ROSEY GRIER LOOKS TO BLITZ PROSTATE CANCER.(U)

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles